Late cardiac tamponade after percutaneous closure of a patent foramen ovale

Thomas Christen1, François Mach, Dominique Didier

  • 1Division of Cardiology, University Hospital, Geneva, Switzerland.

Insights

A patent foramen ovale (PFO) closure device caused late cardiac tamponade in a patient. Device struts eroded the aortic root, leading to hemorrhagic pericardial effusion and highlighting the need for long-term PFO device follow-up.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Patent foramen ovale (PFO) closure is a common procedure for preventing cryptogenic strokes.
  • Percutaneous PFO closure devices are generally considered safe, but potential complications require ongoing investigation.
  • Long-term outcomes and rare adverse events associated with PFO closure devices need thorough documentation.

Observation:

  • A 35-year-old man experienced a transient ischemic attack and subsequently underwent percutaneous PFO closure using a Cardiastar device.
  • One year post-procedure, the patient presented with cardiac tamponade secondary to significant hemorrhagic pericardial effusion.
  • Transesophageal echocardiography revealed device strut impingement on the aortic root near the transverse pericardial sinus.

Findings:

  • Cardiac CT and surgical findings confirmed device strut perforation of the left atrial roof and aortic root.
  • The mechanism is hypothesized to be slow erosion of the aortic wall by a device strut, causing pericardial effusion.
  • This represents the first reported case of late-onset cardiac tamponade following PFO closure.

Implications:

  • This case highlights a rare but serious late complication of PFO closure devices.
  • It underscores the critical importance of long-term patient surveillance and echocardiographic monitoring after PFO device implantation.
  • Further research into device design and long-term biocompatibility may be warranted to prevent such adverse events.

Related Concept Videos